Tuccatinn 150mg Tablet
By BDR PHARMACEUTICALS PVT LTD
150mg
Tuccatinn 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor of the HER2 protein used in the treatment and management of HER2‑positive cancers, especially advanced or metastatic HER2‑positive breast cancer. Tucatinib works by selectively blocking the activity of the HER2 protein, helping to slow disease progression, inhibit tumour growth, and improve overall patient outcomes when used under specialist supervision. Tuccatinn is typically prescribed as part of a comprehensive oncology treatment plan, often in combination with other anticancer medicines, with dosage and schedules determined by the oncologist based on individual patient condition, disease stage, and treatment response.
Price
₹25,800.00 /bottle
₹42,195.00 /bottle
Save 39% off MRP
All prices are inclusive of taxes. Final commercial terms are confirmed on quote.
Dosage
150mg
Pack Size
1 Bottle of 60 Tablets
Active Ingredient / Salt
Tucatinib
Product Description
Tuccatinn 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor of the HER2 protein used in the treatment and management of HER2‑positive cancers, especially advanced or metastatic HER2‑positive breast cancer. Tucatinib works by selectively blocking the activity of the HER2 protein, helping to slow disease progression, inhibit tumour growth, and improve overall patient outcomes when used under specialist supervision. Tuccatinn is typically prescribed as part of a comprehensive oncology treatment plan, often in combination with other anticancer medicines, with dosage and schedules determined by the oncologist based on individual patient condition, disease stage, and treatment response.
Product Info
- Price
- ₹25,800.00 /bottle
- MRP
- ₹42,195.00 /bottle
- Dosage
- 150mg
- Pack Size
- 1 Bottle of 60 Tablets
- Manufacturer
- BDR PHARMACEUTICALS PVT LTD
- Active Ingredient
- Tucatinib
- Category
- Oncology
Key Benefits
- Targets the HER2 pathway involved in specific advanced cancers
- Helps slow progression of HER2‑positive metastatic breast cancer
- Oral tablet form allows convenient daily administration
- Can be used in combination with other targeted therapies for enhanced effectiveness
- Supports specialist‑guided oncology treatment plans
- May improve outcomes in patients who have received prior anticancer therapy
Usage & Safety
Direction for Use
* Take orally with or without food as directed by your oncologist * Swallow the tablet whole; do not crush, chew, or split it * Do not alter dose or schedule without consulting your doctor * Complete the full course unless directed otherwise * Regular follow‑ups recommended to monitor treatment response
Safety Information
* Common side effects may include diarrhoea, nausea, vomiting, mouth sores, decreased appetite, rash, and fatigue, based on known class effects of tucatinib * Serious reactions may include liver problems and severe diarrhoea requiring medical attention * Not recommended during pregnancy or breastfeeding; effective contraception required * Regular monitoring of liver function and other laboratory tests is necessary * Avoid driving or operating machinery if dizziness, fatigue, or other side effects occur * Keep out of reach of children; dispose of unused medicine responsibly * Seek immediate medical attention if severe or unexpected symptoms occur
Allergy Information
* May contain standard excipients * Not suitable for individuals allergic to tucatinib or similar agents
Good to Know
* Manufactured under WHO‑GMP standards * Storage: Store below 30 °C in a dry place * Prescription‑only medicine requiring specialist supervision * Administered according to professional oncology guidelines
Why Choose Tuccatinn 150mg Tablet?
Authentic Product
We source Tuccatinn 150mg Tablet through trusted pharmaceutical channels with an emphasis on authenticity and batch traceability.
Quality Control
Rigorous handling, compliant storage, and careful dispatch planning help protect product integrity.
Fast Delivery
Institutional quote handling and lane planning keep urgent requirements moving without avoidable delays.
Expert Support
Our team helps align pack, category, and procurement details before you finalize a commercial decision.
Alternative Medicines with Same Salt
These alternatives share the same active ingredient or linked molecule record. Please consult your healthcare provider before making any substitutions.
Same salt alternative
Intuca 150mg Tablet
By Intas pharmaceutical pvt ltd · 150mg
Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…
₹4,980.00 /strip
View details
Same salt alternative
Tucaliv 150mg Tablet
HETERO HEALTHCARE PVT LTD · 150mg
Tucaliv 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…
₹24,880.00 /bottle
View details
Same salt alternative
Tucanat 150mg Tablet
Natco Pharma Ltd · 150mg
Tucanat 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…
₹28,100.00 /bottle
View detailsRelated Oncology Products
Explore other products from the same category.
Oncology
Intuca 150mg Tablet
By Intas pharmaceutical pvt ltd · 150mg
Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…
₹4,980.00 /strip
View detailsReady to Order Tuccatinn 150mg Tablet?
Get competitive pricing, institutional support, and confirmed availability for Tuccatinn 150mg Tablet. Share quantity, location, and timeline and our team will respond with the right next step.